Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies

BACKGROUND: Molecular markers that can discriminate indolent cancers from aggressive ones may improve the management of prostate cancer and minimize unnecessary treatment. Aberrant DNA methylation is a common epigenetic event in cancers and HOXD3 promoter hypermethylation (H3PH) has been found in pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Chen, Leonard N, Rubin, Rachel S, Othepa, Eugide, Cer, Caroline, Yun, Elizabeth, Agarwal, Raghunath P, Collins, Brian T, McGeagh, Kevin, Pahira, John, Bandi, Guarav, Kowalczyk, Keith, Kumar, Deepak, Dritschilo, Anatoly, Collins, Sean P, Bostwick, David G, Lynch, John H, Suy, Simeng
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4285328/
https://ncbi.nlm.nih.gov/pubmed/24847526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados